Search

Jan Christop L. Merene

Examiner (ID: 18719, Phone: (571)270-5032 , Office: P/3733 )

Most Active Art Unit
3733
Art Unit(s)
3733, 3773
Total Applications
1047
Issued Applications
660
Pending Applications
88
Abandoned Applications
313

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9435021 [patent_doc_number] => 20140112928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'ANTIBODIES AGAINST TROPOMYOSIN-RELATED KINASE B RECEPTORS' [patent_app_type] => utility [patent_app_number] => 14/116186 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6763 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116186 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/116186
Antibodies against tropomyosin-related kinase B receptors May 17, 2012 Issued
Array ( [id] => 8853552 [patent_doc_number] => 20130143227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'REGULATION OF WNT/BETA-CATENIN SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/475657 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8425 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475657 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/475657
Regulation of Wnt/beta-catenin signaling May 17, 2012 Issued
Array ( [id] => 9463262 [patent_doc_number] => 20140127689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'CXCR1 AS A PREDICTOR OF RESPONSE TO TREATMENT WITH EPIDERMAL GROWTH FACTOR RECEPTOR THERAPEUTIC' [patent_app_type] => utility [patent_app_number] => 14/113783 [patent_app_country] => US [patent_app_date] => 2012-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9629 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113783 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/113783
CXCR1 as a predictor of response to treatment with epidermal growth factor receptor therapeutic Apr 24, 2012 Issued
Array ( [id] => 8347822 [patent_doc_number] => 20120208745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'TREATMENT OF HIV' [patent_app_type] => utility [patent_app_number] => 13/450597 [patent_app_country] => US [patent_app_date] => 2012-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4615 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450597 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/450597
TREATMENT OF HIV Apr 18, 2012 Abandoned
Array ( [id] => 8441428 [patent_doc_number] => 20120258045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'INHIBITORS AND METHODS OF TREATMENT OF CARDIOVASCULAR DISEASES, AND METHODS FOR IDENTIFYING INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/448223 [patent_app_country] => US [patent_app_date] => 2012-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12572 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448223 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/448223
INHIBITORS AND METHODS OF TREATMENT OF CARDIOVASCULAR DISEASES, AND METHODS FOR IDENTIFYING INHIBITORS Apr 15, 2012 Abandoned
Array ( [id] => 10932068 [patent_doc_number] => 20140335090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'THERAPEUTIC AGENT FOR CANCER, AND METHOD FOR DETERMINING PROGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/009026 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3423 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009026 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/009026
THERAPEUTIC AGENT FOR CANCER, AND METHOD FOR DETERMINING PROGNOSIS OF CANCER Mar 29, 2012 Abandoned
Array ( [id] => 9756251 [patent_doc_number] => 20140286952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'Inhibitors of Metastasis, Methods of Generating Such Inhibitors and Their Therapeutic Applications' [patent_app_type] => utility [patent_app_number] => 14/007683 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 22816 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007683 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/007683
Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications Mar 29, 2012 Issued
Array ( [id] => 9517745 [patent_doc_number] => 20140154238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'Compositions And Methods For Treating, Diagnosing And Monitoring Disease' [patent_app_type] => utility [patent_app_number] => 14/007932 [patent_app_country] => US [patent_app_date] => 2012-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9360 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007932 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/007932
Compositions and methods for treating, diagnosing and monitoring disease Mar 27, 2012 Issued
Array ( [id] => 9656265 [patent_doc_number] => 20140227270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS' [patent_app_type] => utility [patent_app_number] => 14/008011 [patent_app_country] => US [patent_app_date] => 2012-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 54306 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008011 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/008011
BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS Mar 27, 2012 Abandoned
Array ( [id] => 9656265 [patent_doc_number] => 20140227270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS' [patent_app_type] => utility [patent_app_number] => 14/008011 [patent_app_country] => US [patent_app_date] => 2012-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 54306 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008011 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/008011
BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS Mar 27, 2012 Abandoned
Array ( [id] => 8417577 [patent_doc_number] => 20120245077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'PROKINETICIN 1 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/429773 [patent_app_country] => US [patent_app_date] => 2012-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 33427 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13429773 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/429773
PROKINETICIN 1 RECEPTOR Mar 25, 2012 Abandoned
Array ( [id] => 9293994 [patent_doc_number] => 20140037628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/110189 [patent_app_country] => US [patent_app_date] => 2012-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17001 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110189 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/110189
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer Mar 20, 2012 Issued
Array ( [id] => 9211579 [patent_doc_number] => 20140010756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER' [patent_app_type] => utility [patent_app_number] => 14/006048 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14632 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006048 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/006048
COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER Mar 15, 2012 Abandoned
Array ( [id] => 9211579 [patent_doc_number] => 20140010756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER' [patent_app_type] => utility [patent_app_number] => 14/006048 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14632 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006048 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/006048
COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER Mar 15, 2012 Abandoned
Array ( [id] => 8489469 [patent_doc_number] => 20120288876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'NOVEL IDENTIFIED ONCOGENE WITH KINASE-DOMAIN (NOK)' [patent_app_type] => utility [patent_app_number] => 13/419096 [patent_app_country] => US [patent_app_date] => 2012-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12289 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13419096 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/419096
NOVEL IDENTIFIED ONCOGENE WITH KINASE-DOMAIN (NOK) Mar 12, 2012 Abandoned
Array ( [id] => 9295262 [patent_doc_number] => 20140038897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'TFEB VARIANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/003505 [patent_app_country] => US [patent_app_date] => 2012-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12193 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003505 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/003505
TFEB variants and uses thereof Mar 6, 2012 Issued
Array ( [id] => 9572180 [patent_doc_number] => 20140189893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'METHOD OF IDENTIFYING COMPOUNDS THAT SPECIFICALLY MODULATE THE INTERACTION OF FGFR1 AND BETA KLOTHO' [patent_app_type] => utility [patent_app_number] => 14/116406 [patent_app_country] => US [patent_app_date] => 2012-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12128 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116406 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/116406
METHOD OF IDENTIFYING COMPOUNDS THAT SPECIFICALLY MODULATE THE INTERACTION OF FGFR1 AND BETA KLOTHO Feb 19, 2012 Abandoned
Array ( [id] => 8710314 [patent_doc_number] => 20130067603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'SPERM-SPECIFIC CATION CHANNEL, CATSPER4, AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/371033 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20065 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13371033 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/371033
Sperm-specific cation channel, CatSper4, and uses therefor Feb 9, 2012 Issued
Array ( [id] => 11283739 [patent_doc_number] => 09499584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-22 [patent_title] => 'GPCR with improved cell surface expression' [patent_app_type] => utility [patent_app_number] => 14/375316 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8897 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375316 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/375316
GPCR with improved cell surface expression Jan 30, 2012 Issued
Array ( [id] => 10375716 [patent_doc_number] => 20150260724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'CELL BASED SENSOR' [patent_app_type] => utility [patent_app_number] => 14/375334 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10592 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375334 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/375334
Cell based sensor Jan 30, 2012 Issued
Menu